Home / Inspections / 1299156

FDA Inspection 1299156 — Magdalena Woroszyl, MD

Magdalena Woroszyl, MD — FEI 3040664566

The FDA completed an inspection of Magdalena Woroszyl, MD on Dec 19, 2025 in Warsaw. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Dec 19, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Warsaw (Poland)

Additional details

Clinical Investigator (CI)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.